Double-blind Placebo Controlled Dose-ranging Study for the Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Oral Dosing of GLPG0634 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Feb 2015
At a glance
- Drugs Filgotinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 11 Nov 2012 Results will be presented at the 2012 Annual Meeting of the American College of Rheumatology (ACR) according to a Galapagos media release.
- 25 Oct 2011 Actual end date (1 Oct 2011) added as reported by ClinicalTrials.gov.
- 25 Oct 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.